The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Action of epoxyeicosatrienoic acids on cellular function
Abstract
Epoxyeicosatrienoic acids (EETs), which function primarily as autocrine and paracrine mediators in the cardiovascular and renal systems, are synthesized from arachidonic acid by cytochrome P-450 epoxygenases. They activate smooth muscle large-conductance Ca 2+-activated K+ channels, producing hyperpolarization and vasorelaxation. EETs also have anti-inflammatory effects in the vasculature and kidney, stimulate angiogenesis, and have mitogenic effects in the kidney. Many of the functional effects of EETs occur through activation of signal transduction pathways and modulation of gene expression, events probably initiated by binding to a putative cell surface EET receptor. However, EETs are rapidly taken up by cells and are incorporated into and released from phospholipids, suggesting that some functional effects may occur through a direct interaction between the EET and an intracellular effector system. In this regard, EETs and several of their metabolites activate peroxisome proliferator-activated receptor α (PPARα) and PPARγ, suggesting that some functional effects may result from PPAR activation. EETs are metabolized primarily by conversion to dihydroxyeicosatrienoic acids (DHETs), a reaction catalyzed by soluble epoxide hydrolase (sEH). Many potentially beneficial actions of EETs are attenuated upon conversion to DHETs, which do not appear to be essential under routine conditions. Therefore, sEH is considered a potential therapeutic target for enhancing the beneficial functions of EETs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Roman, R. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00021.2001 · Cited by 1,309
Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing Factors
Campbell, W. B., Gebremedhin, D., Pratt, P. F., & Harder, D. R. (1996) · Circulation Research · doi:10.1161/01.res.78.3.415 · Cited by 1,221
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,215
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786 · cited 2×
“In addition, each of the PPARs has specific anti-inflammatory properties when they are activated (49).”
BackgroundPeroxisome proliferator-activated receptors in inflammation control
Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755 · cited 2×
“Both PPAR and PPAR are expressed in endothelial cells and blood vessels (27, 28), indicating that they have a role in vascular function.”
BackgroundMukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 1×
“Another epoxide derivative of DHA, 16,17-epoxy-docosatriene, is an intermediate in the pathway that produces neuroprotectin D1 in human ARPE-19 cells (113).”
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Epoxygenase Pathways of Arachidonic Acid Metabolism
Zeldin, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100030200 · Cited by 654
Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function
Spector, A. A., Fang, X., Snyder, G. D., & Weintraub, N. L. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00049-3 · Cited by 589
Self-citationArachidonic acid as a bioactive molecule
Brash, A. R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13210 · Cited by 571
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 552
Kunau, W. (1995) · Progress in Lipid Research · doi:10.1016/0163-7827(95)00011-9 · Cited by 510
Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchart, J.-C., Najib, J., Duriez, P., & Staels, B. (1999) · Circulation Research · doi:10.1161/01.res.85.5.394 · Cited by 502
Endothelium-Derived Hyperpolarizing Factor: Where Are We Now?
Félétou, M., & Vanhoutte, P. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000217611.81085.c5 · Cited by 488
Epoxide hydrolases: their roles and interactions with lipid metabolism
Newman, J. W., Morisseau, C., & Hammock, B. D. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.10.001 · Cited by 474
Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., & Zeldin, D. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3460 · Cited by 473
Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids
Yu, Z., Xu, F., Huse, L. M., Morisseau, C., Draper, A. J., Newman, J. W., Parker, C., Graham, L., Engler, M. M., Hammock, B. D., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.11.992 · Cited by 467
TRPV4 Forms a Novel Ca 2+ Signaling Complex With Ryanodine Receptors and BK Ca Channels
Earley, S., Heppner, T. J., Nelson, M. T., & Brayden, J. E. (2005) · Circulation Research · doi:10.1161/01.res.0000194321.60300.d6 · Cited by 452
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
Schmelzer, K. R., Kubala, L., Newman, J. W., Kim, I.-H., Eiserich, J. P., & Hammock, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503279102 · Cited by 441
Nitrolinoleic acid. An endogenous peroxisome proliferator-activated receptor γ ligand
Schopfer, F. J., Lin, Y., Baker, P. R. S., Cui, T., Garcia-Barrio, M., Zhang, J., Chen, K., Chen, Y. E., & Freeman, B. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408384102 · Cited by 428
Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα
Moya-Camarena, S. Y., Heuvel, J. P. V., Blanchard, S. G., Leesnitzer, L. A., & Belury, M. A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33384-8 · Cited by 396
Cytochrome P450 and Vascular Homeostasis
Fleming, I. (2001) · Circulation Research · doi:10.1161/hh2101.099268 · Cited by 383
Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25252 · Cited by 378
Vriens, J., Owsianik, G., Fisslthaler, B., Suzuki, M., Janssens, A., Voets, T., Morisseau, C., Hammock, B. D., Fleming, I., Busse, R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000187474.47805.30 · Cited by 365
Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation
Sinal, C. J., Miyata, M., Tohkin, M., Nagata, K., Bend, J. R., & Gonzalez, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m008106200 · Cited by 341
Delivery and turnover of plasma-derived essential PUFAs in mammalian brain
Rapoport, S. I., Chang, M. C. J., & Spector, A. A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31629-1 · Cited by 330
Self-citationSpector, A. A. (1999) · Lipids · doi:10.1007/bf02562220 · Cited by 310
Self-citationRole of Cytochrome P-450 Enzymes and Metabolites of Arachidonic Acid in the Control of Vascular Tone
Harder, D. R., Campbell, W. B., & Roman, R. J. (1995) · Journal of Vascular Research · doi:10.1159/000159080 · Cited by 301
Liu, Y., Zhang, Y., Schmelzer, K., Lee, T.-S., Fang, X., Zhu, Y., Spector, A. A., Gill, S., Morisseau, C., Hammock, B. D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508081102 · Cited by 300
Self-citationCytochrome P-450 Metabolism of Arachidonic Acid
McGiff, J. C. (1991) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.31.040191.002011 · Cited by 292
Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G., & Wahli, W. (1993) · Biology of the Cell · doi:10.1016/s0248-4900(05)80176-5 · Cited by 284
Seubert, J., Yang, B., Bradbury, J. A., Graves, J., Degraff, L. M., Gabel, S., Gooch, R., Foley, J., Newman, J., Mao, L., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000139436.89654.c8 · Cited by 273
Li, P.-L., & Campbell, W. B. (1997) · Circulation Research · doi:10.1161/01.res.80.6.877 · Cited by 257
Imig, J. D., Zhao, X., Zaharis, C. Z., Olearczyk, J. J., Pollock, D. M., Newman, J. W., Kim, I.-H., Watanabe, T., & Hammock, B. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000176237.74820.75 · Cited by 257
Oltman, C. L., Weintraub, N. L., VanRollins, M., & Dellsperger, K. C. (1998) · Circulation Research · doi:10.1161/01.res.83.9.932 · Cited by 249
Westergaard, M., Henningsen, J., Kratchmarova, I., Kristiansen, K., Svendsen, M. L., Johansen, C., Jensen, U. B., Schrøder, H. D., Berge, R. K., Iversen, L., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01329.x · Cited by 241
Node, K., Ruan, X.-L., Dai, J., Yang, S.-X., Graham, L., Zeldin, D. C., & Liao, J. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100439200 · Cited by 234
Regulated formation of eicosanoids
Fitzpatrick, F. A., & Soberman, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13241 · Cited by 233
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Imig, J. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00350.2004 · Cited by 233
Argiriadi, M. A., Morisseau, C., Hammock, B. D., & Christianson, D. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10637 · Cited by 228
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Zhao, X., Yamamoto, T., Newman, J. W. I., Kim, I.-H., Watanabe, T., Hammock, B. D., Stewart, J. P., Pollock, J. S., Pollock, D. M., & Imig, J. D. (2004) · PubMed · Cited by 222
Newman, J. W., Morisseau, C., Harris, T. R., & Hammock, B. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437724100 · Cited by 219
Graier, W. F., Simecek, S., & Sturek, M. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020515 · Cited by 208
Wang, Y., Wei, X., Xiao, X., Hui, R., Card, J. W., Carey, M. A., Wang, D. W., & Zeldin, D. C. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083477 · Cited by 205
Campbell, W. B., & Harder, D. R. (1999) · Circulation Research · doi:10.1161/01.res.84.4.484 · Cited by 205
Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells
Fang, X., Kaduce, T. L., Weintraub, N. L., Harmon, S., Teesch, L. M., Morisseau, C., Thompson, D. A., Hammock, B. D., & Spector, A. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011761200 · Cited by 198
Self-citationCowart, L. A., Wei, S., Hsu, M.-H., Johnson, E. F., Krishna, M. U., Falck, J. R., & Capdevila, J. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201575200 · Cited by 195
Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function
Seubert, J. M., Sinal, C. J., Graves, J., DeGraff, L. M., Bradbury, J. A., Lee, C. R., Goralski, K., Carey, M. A., Luria, A., Newman, J. W., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000237390.92932.37 · Cited by 195
Cytochrome P450 pathways of arachidonic acid metabolism
Kroetz, D. L., & Zeldin, D. C. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00007 · Cited by 193
Hu, S., & Kim, H. S. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90805-r · Cited by 193
Plasma Free Fatty Acid and Lipoproteins as Sources of Polyunsaturated Fatty Acid for the Brain
Spector, A. A. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:2-3:159 · Cited by 189
Self-citationGomez, G. A., Morisseau, C., Hammock, B. D., & Christianson, D. W. (2004) · Biochemistry · doi:10.1021/bi036189j · Cited by 186
20-HETE and the kidney: resolution of old problems and new beginnings
McGiff, J. C., & Quilley, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r607 · Cited by 186
Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity
Zou, A. P., Fleming, J. T., Falck, J. R., Jacobs, E. R., Gebremedhin, D., Harder, D. R., & Roman, R. J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f822 · Cited by 185
Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced Hypertension
Jung, O., Brandes, R. P., Kim, I.-H., Schweda, F., Schmidt, R., Hammock, B. D., Busse, R., & Fleming, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000153792.29478.1d · Cited by 180
Pozzi, A., Macias-Perez, I., Abair, T., Wei, S., Su, Y., Zent, R., Falck, J. R., & Capdevila, J. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501730200 · Cited by 178
Tzameli, I., Fang, H., Ollero, M., Shi, H., Hamm, J. K., Kievit, P., Hollenberg, A. N., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405346200 · Cited by 178
Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids
Spiecker, M., & Liao, J. K. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.10.009 · Cited by 178
Michaelis, U. R., Fisslthaler, B., Barbosa-Sicard, E., Falck, J. R., Fleming, I., & Busse, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02674 · Cited by 173
Larsen, B. T., Miura, H., Hatoum, O. A., Campbell, W. B., Hammock, B. D., Zeldin, D. C., Falck, J. R., & Gutterman, D. D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00927.2005 · Cited by 172
Sun, J., Sui, X., Bradbury, J. A., Zeldin, D. C., Conte, M. S., & Liao, J. K. (2002) · Circulation Research · doi:10.1161/01.res.0000017727.35930.33 · Cited by 171
Hostetler, H. A., Petrescu, A. D., Kier, A. B., & Schroeder, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412062200 · Cited by 169
Michaelis, U. R., Fisslthaler, B., Medhora, M., Harder, D., Fleming, I., & Busse, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0640fje · Cited by 169
Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9.
Daikh, B. E., Lasker, J. M., Raucy, J. L., & Koop, D. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24028-9 · Cited by 165
Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
Chen, J., Capdevila, J. H., Zeldin, D. C., & Rosenberg, R. L. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12026-3 · Cited by 165
Rosolowsky, M., & Campbell, W. B. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00216-2 · Cited by 158
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase
Cronin, A., Mowbray, S. L., Dürk, H., Homburg, S., Fleming, I., Fißlthaler, B., Oesch, F., & Arand, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437829100 · Cited by 157
Potente, M., Fißlthaler, B., Busse, R., & Fleming, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305385200 · Cited by 155
Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis
Chen, J., Capdevila, J. H., & Harris, R. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6322-6331.2001 · Cited by 152
Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenates
Oliw, E. H. (1994) · Progress in Lipid Research · doi:10.1016/0163-7827(94)90029-9 · Cited by 148
Karara, A., Dishman, E., Falck, J. R., & Capdevila, J. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89484-8 · Cited by 147
Ye, D., Zhang, D., Oltman, C. L., Dellsperger, K. C., Lee, H.-C., & VanRollins, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.303.2.768 · Cited by 146
Endothelium-Derived Hyperpolarizing Factor
Komori, K., & Vanhoutte, P. M. (2008) · Blood Vessels · doi:10.1159/000158815 · Cited by 146
EET homologs potently dilate coronary microvessels and activate BKCachannels
Zhang, Y., Oltman, C. L., Lü, T., Lee, H.-C., Dellsperger, K. C., & VanRollins, M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.6.h2430 · Cited by 144
Biochemical Characterization of the Human Liver Cytochrome P450 Arachidonic Acid Epoxygenase Pathway
Zeldin, D. C., Moomaw, C. R., Jesse, N., et al. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0229 · Cited by 142
Krötz, F., Riexinger, T., Buerkle, M. A., Nithipatikom, K., GLOE, T. R., Sohn, H., Campbell, W. B., & Pohl, U. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000116219.09040.8c · Cited by 134
Alternative Splicing Determines the Function of CYP4F3 by Switching Substrate Specificity
Christmas, P., Jones, J. P., Patten, C., Rock, D. A., Zheng, Y., Cheng, S., Weber, B. M., Carlesso, N., Scadden, D. T., Rettie, A. E., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104818200 · Cited by 133
Chen, J., Falck, J. R., Reddy, K. M., Capdevila, J. H., & Harris, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29254 · Cited by 133
Munzenmaier, D. H., & Harder, D. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1163 · Cited by 131
Dorrance, A. M., Rupp, N., Pollock, D. M., Newman, J. W. I., Hammock, B. D., & Imig, J. D. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000189600.74157.6d · Cited by 130
Potentiation of Endothelium-Dependent Relaxation by Epoxyeicosatrienoic Acids
Weintraub, N. L., Fang, X., Kaduce, T. L., VanRollins, M., Chatterjee, P., & Spector, A. A. (1997) · Circulation Research · doi:10.1161/01.res.81.2.258 · Cited by 128
Self-citationEndothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function
Fleming, I., & Busse, R. (2006) · Hypertension · doi:10.1161/01.hyp.0000208597.87957.89 · Cited by 128
Michaelis, U. R., & Fleming, I. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.003 · Cited by 127
The CYP P450 Arachidonic Acid Monooxygenases: From Cell Signaling to Blood Pressure Regulation
Capdevila, J. H., & Falck, J. R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5167 · Cited by 127
Göttlicher, M., Demoz, A., Svensson, D., Tollet, P., Berge, R. K., & Gustafsson, J.-Α. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90607-x · Cited by 123
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
Davis, B. B., Thompson, D. A., Howard, L. L., Morisseau, C. H. P., Hammock, B. D., & Weiss, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261710799 · Cited by 120
Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators
Lauterbach, B., Barbosa‐Sicard, E., Wang, M.-H., Honeck, H., Kärgel, E., Theuer, J., Schwartzman, M. L., Haller, H. G., Luft, F. C., Gollasch, M., et al. (2002) · Hypertension · doi:10.1161/hy0202.103293 · Cited by 120
Huang, A., Sun, D., Jacobson, A., Carroll, M. A., Falck, J. R., & Kaley, G. (2005) · Circulation Research · doi:10.1161/01.res.0000155332.17783.26 · Cited by 118
Li, P., Cai-lian, C., Bortell, R., & Campbell, W. B. (1999) · Circulation Research · doi:10.1161/01.res.85.4.349 · Cited by 117
Williard, D. E., Harmon, S. D., Kaduce, T. L., Preuss, M. A., Moore, S. A., Robbins, M. E. C., & Spector, A. A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30268-6 · Cited by 116
Self-citationGranlund, L., Juvet, L. K., Pedersen, J. I., & Nebb, H. I. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300120-jlr200 · Cited by 115
Potente, M., Michaelis, U. R., Fißlthaler, B., Busse, R., & Fleming, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110806200 · Cited by 114
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-α
Fang, X., Hu, S., Bingkun, X., Snyder, G. D., Harmon, S. D., Yao, J., Liu, Y., Sangras, B., Falck, J. R., Weintraub, N. L., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00427.2005 · Cited by 114
Self-citationChen, J., Wang, D. W., Falck, J. R., Capdevila, J. H., & Harris, R. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4764 · Cited by 111
Carroll, M. A., Balazy, M., Margiotta, P., Falck, J. R., & McGiff, J. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31383-8 · Cited by 110
Fleming, I., Fißlthaler, B., Michaelis, R., Kiss, L., Popp, R., & Busse, R. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100565 · Cited by 106
Karara, A., Wei, S., Spady, D. K., Swift, L. L., Capdevila, J. H., & Falck, J. R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91877-s · Cited by 106
Lee, H. C., Lü, T., Weintraub, N. L., VanRollins, M., Spector, A. A., & Shibata, E. F. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0153o.x · Cited by 105
Self-citationCorton, J. C., Fan, L.-Q., Brown, S. S., Anderson, S. P., Bocos, C., Cattley, R. C., Mode, A., & Gustafsson, J.-Α. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.463 · Cited by 102
Muller, D., Theuer, J., Shagdarsuren, E., Kaergel, E., Honeck, H., Park, J.-K., Marković, M., Barbosa-Sicard, E., Dechend, R., Wellner, M., et al. (2004) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63142-2 · Cited by 101
14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells.
VanRollins, M., Kaduce, T. L., Knapp, H. R., & Spector, A. A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35111-7 · Cited by 100
Self-citationLü, T., Hoshi, T., Weintraub, N. L., Spector, A. A., & Lee, H.-C. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00811.x · Cited by 98
Self-citationFang, X., Kaduce, T. L., Weintraub, N. L., VanRollins, M., & Spector, A. A. (1996) · Circulation Research · doi:10.1161/01.res.79.4.784 · Cited by 96
Self-citationEicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily
Barbosa‐Sicard, E., Markovic, M., Honeck, H., Christ, B., Müller, D. N., & Schunck, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.103 · Cited by 94
Murakami, K., Ide, T., Suzuki, M., Mochizuki, T., & Kadowaki, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0951 · Cited by 92
Chen, J., Capdevila, J. H., & Harris, R. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092671899 · Cited by 91
Identification of Arachidonate P-450 Metabolites in Human Platelet Phospholipids
Zhu, Y., Eb, S., McGiff, J. C., & Balazy, M. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.854 · Cited by 87
Lü, T., Katakam, P. V. G., VanRollins, M., Weintraub, N. L., Spector, A. A., & Lee, H. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.t01-1-00651.x · Cited by 86
Self-citationFang, X., Weintraub, N. L., McCaw, R. B., Hu, S., Harmon, S. D., Rice, J. B., Hammock, B. D., & Spector, A. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00527.2004 · Cited by 85
Self-citationZeldin, D. C., Foley, J. F., Boyle, J. E., Moomaw, C. R., Tomer, K. B., Parker, C. E., Steenbergen, C., & Wu, S. (1997) · Endocrinology · doi:10.1210/en.138.3.1338 · Cited by 85
Widstrom, R. L., Norris, A. W., & Spector, A. A. (2001) · Biochemistry · doi:10.1021/bi001602y · Cited by 83
Self-citationVanRollins, M., Kaduce, T. L., Fang, X., Knapp, H. R., & Spector, A. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14001 · Cited by 82
Self-citationWong, P. Y.-K., Lai, P.-S., & Falck, J. R. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00079-4 · Cited by 82
Weintraub, N. L., Fang, X., Kaduce, T. L., VanRollins, M., Chatterjee, P., & Spector, A. A. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.5.h2098 · Cited by 76
Self-citationMichaelis, U. R., Falck, J. R., Schmidt, R., Busse, R., & Fleming, I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000151648.58516.eb · Cited by 74
Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids.
Bernström, K., Kayganich, K. A., Murphy, R. C., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50579-8 · Cited by 72
Laminar Flow Activates Peroxisome Proliferator-Activated Receptor-γ in Vascular Endothelial Cells
Liu, Y., Zhu, Y., Rannou, F., et al. (2004) · Circulation · doi:10.1161/01.cir.0000139850.08365.ec · Cited by 72
Karara, A., Dishman, E., Jacobson, H., Falck, J. R., & Capdevila, J. H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81014-f · Cited by 70
Fang, X., Hu, S., Watanabe, T., Weintraub, N. L., Snyder, G. D., Yao, J., Liu, Y., Shyy, J. Y.-J., Hammock, B. D., & Spector, A. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085605 · Cited by 70
Self-citationSellers, K. W., Sun, C., Díez-Freire, C., Waki, H., Morisseau, C. H. P., Falck, J. R., Hammock, B. D., Paton, J. F. R., & Raizada, M. K. (2005) · The FASEB Journal · doi:10.1096/fj.04-3128fje · Cited by 68
Fang, X., Weintraub, N. L., Stoll, L. L., & Spector, A. A. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1242 · Cited by 66
Self-citationVascular localization of soluble epoxide hydrolase in the human kidney
Yu, Z., Davis, B. B., Morisseau, C. H. P., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00165.2003 · Cited by 66
Lü, T., VanRollins, M., & Lee, H.-C. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1076 · Cited by 64
Dussault, I., & FORMAN, B. M. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00071-x · Cited by 63
20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells
Kaduce, T. L., Fang, X., Harmon, S. D., Oltman, C. L., Dellsperger, K. C., Teesch, L. M., Gopal, V. R., Falck, J. R., Campbell, W. B., Weintraub, N. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306849200 · Cited by 60
Self-citationRingseis, R., Müller, A., Herter, C., Gahler, S., Steinhart, H., & Eder, K. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.002 · Cited by 57
EETs relax airway smooth muscle via an EpDHF effect: BKCachannel activation and hyperpolarization
Benoît, C., Renaudon, B., Salvail, D., & Rousseau, É. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.5.l965 · Cited by 55
Hoebel, B. G., & Graier, W. F. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00118-6 · Cited by 53
Collins, X. H., Harmon, S. D., Kaduce, T. L., Berst, K. B., Fang, X., Moore, S. A., Raju, T. V., Falck, J. R., Weintraub, N. L., Duester, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504055200 · Cited by 52
Self-citationZhao, X., Quigley, J. E., Yuan, J., Wang, M.-H., Zhou, Y., & Imig, J. D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00937.2005 · Cited by 51
Chen, J.-K., Capdevila, J. H., & Harris, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13789 · Cited by 50
Fang, X., Dillon, J. S., Hu, S., Harmon, S. D., Yao, J., Anjaiah, S., Falck, J. R., & Spector, A. A. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.002 · Cited by 46
Self-citationShivachar, A. C., Willoughby, K. A., & Ellis, E. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010338.x · Cited by 45
Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide
Fang, X., Weintraub, N. L., Oltman, C. L., Stoll, L. L., Kaduce, T. L., Harmon, S. D., Dellsperger, K. C., Morisseau, C. H. P., Hammock, B. D., & Spector, A. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00448.2002 · Cited by 45
Self-citationFang, X., Kaduce, T. L., Weintraub, N. L., & Spector, A. A. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90412-9 · Cited by 43
Self-citationHarmon, S. D., Fang, X., Kaduce, T. L., Hu, S., Gopal, V. R., Falck, J. R., & Spector, A. A. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.005 · Cited by 42
Self-citationWidstrom, R. L., Norris, A. W., Veer, J. V. D., & Spector, A. A. (2003) · Biochemistry · doi:10.1021/bi034971d · Cited by 42
Self-citationAhR and PPARa: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11
Shaban, Z., Soliman, M. M., El-Shazly, S. A., Elbohi, K. M., Abdelazeez, A., Kehelo, K., Kim, H., Muzandu, K. M., Ishizuka, M., Kazusaka, A., et al. (2005) · Xenobiotica · doi:10.1080/00498250400021804 · Cited by 39
Fang, X., Kaduce, T. L., VanRollins, M., Weintraub, N. L., & Spector, A. A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32075-7 · Cited by 38
Self-citationRipp, S. L., Falkner, K. C., Pendleton, M. L., Tamási, V., & Prough, R. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.113 · Cited by 29
Helledie, T., Jørgensen, C., Antonius, M., Krogsdam, A., Kratchmarova, I., Kristiansen, K., & Mandrup, S. (2002) · Springer eBooks · doi:10.1007/978-1-4419-9270-3_20 · Cited by 28
Fang, X., Weintraub, N. L., & Spector, A. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00002-9 · Cited by 24
Self-citationCampbell, W. B., Holmes, B. B., Falck, J. R., Capdevila, J. H., & Gauthier, K. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00516.2005 · Cited by 23
Molecular Determinants of Cardiac KATP Channel Activation by Epoxyeicosatrienoic Acids
Lü, T., Hong, M.-P., & Lee, H.-C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414065200 · Cited by 22
Sex‐and age‐related differences in ceramide dihexosides of primary human brain tumors
Yates, A. J., Franklin, T. K., Scheithauer, B., Burger, P. C., & Pearl, D. K. (1999) · Lipids · doi:10.1007/s11745-999-330-7 · Cited by 21
Direct modulation of tracheal Cl−-channel activity by 5,6- and 11,12-EET
Salvail, D., Dumoulin, M., & Rousseau, É. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.3.l432 · Cited by 21
Cited by
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
Imig, J. D., & Hammock, B. D. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2875 · Cited by 614
Generation and Biological Activities of Oxidized Phospholipids
Bochkov, V. N., Oskolkova, O. V., Birukov, K. G., Levonen, A.-L., Binder, C. J., & Stöckl, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2597 · Cited by 610
A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice
Mitchell, C., & Willenbring, H. (2008) · Nature Protocols · doi:10.1038/nprot.2008.80 · Cited by 577
Metadata
- Authors
- Spector, A. A., & Norris, A. W.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2007-03
- Volume
- 292
- Issue
- 3
- Pages
- C996-C1012
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2135910732
- Cited by
- 477
- References
- 152
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.